| Word | Abbreviation |
| Conventional drug delivery systems | CDDSs |
| Food and Drug Administration | FDA |
| European Medicines Agency | EMA |
| Active pharmaceutical ingredients | APIs |
| Nanoparticles | NPs |
| Enhanced permeability and retention | EPR |
| Gastrointestinal tract | GIT |
| Reticuloendothelial system | RES |
| Central nervous system | CNS |
| Poly(butylcyanoacrylate) | PBCA |
| Poly(lactic-co-glycolic acid) | PLGA |
| Poly(lactic acid) | PLA |
| Federal Food, Drug, and Cosmetic Act | FDCA |
| Public Health Service Act | PHSA |
| Nonbiological complex drugs | NBCDs |
| Pharmacokinetics | PK |
| Chemistry, manufacturing, and controls | CMC |
| Nuclear magnetic resonance | NMR |
| Mass spectrometry | MS |
| Research and development | R&D |
| World Health Organization | WHO |
| Polyethylene glycol | PEG |